Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

California

NEW

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

NEW

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

NEW

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

NEW

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

NEW

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

PAREXEL
Glendale California 91206

Mild Cognitive Impairment

Alliance Research Center
Laguna Hills California 92653

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Excell Research, Inc.
Oceanside California 92056

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Asclepes Research Center
Panorama City California 91402

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

San Francisco Clinical Research Center
San Francisco California 94530

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Schuster Medical Research Institute
Sherman Oaks California 91403

Have you had a slow progression of memory decline in the last year or so?

Schuster Medical Research Institute
Sherman Oaks California 91403

Have you had a slow progression of memory decline in the last year or so?

Connecticut

Chase Medical Research, LLC
Waterbury Connecticut 06708

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NOURISH AD)

Florida

Bradenton Research Center
Bradenton Florida 34205

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

MD Clinical
Hallandale Beach Florida 33009

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

MD Clinical
Hallandale Beach Florida 33009

Do you know someone with Memory Loss?

New Horizon Research Center
Miami Florida 33175

A 24-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease

IMIC, Inc.
Miami Florida 33157

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Panax Clincial Research LLC
Miami Lakes Florida 33014

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Lazlo Mate, MD
North Palm Beach Florida 33408

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Neurostudies, Inc.
Port Charlotte Florida 33952

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Progressive Medical Research
Port Orange Florida 32127

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Stedman Clinical Trials
Tampa Florida 33613

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Tampa Florida 33613

A clinical trial to evaluate treatments using Resonator for patients with Alzheimer's Dementia

Georgia

NeuroStudies.net, LLC
Decatur Georgia 30033

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

A randomised, double-blind, parallel-group, placebo-controlled, fixed dose study of study drug in patients with mild-moderate Alzheimer's disease treated with donepezil

NeuroStudies.net, LLC
Decatur Georgia 30033

An exploratory, paired biomarker study in subjects with Alzheimer's disease vs. healthy subjects

NeuroStudies.net, LLC
Decatur Georgia 30033

Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers

Illinois

Behavioral Health Care Associates
Schaumburg Illinois 60193

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Kansas

Precise Clinical Research
Topeka Kansas 66604

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Maine

Eastern Maine Medical Center
Bangor Maine 04401

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Massachusetts

ActiveMed
Methuen Massachusetts 01844

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Michigan

QUEST Research Institute
Bingham Farms Michigan 48025

Treatment to slow the rate of memory loss possibly due to mild cognitive impairment or Alzheimer's disease.

New Hampshire

ActiveMed
Portsmouth New Hampshire 03801

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New Jersey

Memory Enhancement Center of America
Eatontown New Jersey 07724

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Premier Urology Associates, LLC
Lawrenceville New Jersey 08648

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

The NeuroCognitive Institute
Mt. Arlington New Jersey 07856

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New Mexico

Albuquerque Neuroscience
Albuquerque New Mexico 87109

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New York

NEW

SPRI Clinical Trials Brooklyn
Brooklyn New York 11235

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

NEW

SPRI Clinical Trials Brooklyn
Brooklyn New York 11235

An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)

Manhattan Behavioral Medicine
New York New York 10023

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Medical Research Network
New York New York 10128

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Clinilabs, Inc.
New York New York 10019

Do you suffer from Alzheimer's?

Winifred Masterson Burke Medical Research Institute
White Plains New York 10605

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

New York New York 10032

A clinical trial to evaluate treatments using cocoa flavanols for patients with Memory Loss

North Carolina

ANI Neurology, PLLC Alzheimer's Memory Center
Charlotte North Carolina 28270

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease